BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Colorectal cancer AND SALL4, ENSG00000101115, 57167, Q9UJQ4, ZNF797, MGC133050, HSAL4, DRRS, dJ1112F19_1 AND Prognosis
8126 results:

  • 1. Transcranial Direct Current Stimulation for Anxiety During Laparoscopic colorectal cancer Surgery: A Randomized Clinical Trial.
    Li C; Tao M; Chen D; Wei Q; Xiong X; Zhao W; Tan W; Yang J; Han Y; Zhang H; Zhang S; Liu H; Cao JL
    JAMA Netw Open; 2024 Apr; 7(4):e246589. PubMed ID: 38635271
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Relationship of FDG PET/CT imaging features with tumor immune microenvironment and prognosis in colorectal cancer: a retrospective study.
    Lee JW; Ahn H; Yoo ID; Hong SP; Baek MJ; Kang DH; Lee SM
    Cancer Imaging; 2024 Apr; 24(1):53. PubMed ID: 38627864
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Inhibition of autophagy-related protein 7 enhances anti-tumor immune response and improves efficacy of immune checkpoint blockade in microsatellite instability colorectal cancer.
    Zhang W; Chen L; Liu J; Chen B; Shi H; Chen H; Qi H; Wu Z; Mao X; Wang X; Huang Y; Li J; Yu Z; Zhong M; Wang T; Li Q
    J Exp Clin Cancer Res; 2024 Apr; 43(1):114. PubMed ID: 38627815
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. The role of piRNAs in predicting and prognosing in cancer: a focus on piRNA-823 (a systematic review and meta-analysis).
    Taghizadeh M; Jafari-Koshki T; Jafarlou V; Raeisi M; Alizadeh L; Roosta Y; Matin S; Jabari R; Sur D; Karimi A
    BMC Cancer; 2024 Apr; 24(1):484. PubMed ID: 38627675
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Predictive value of red blood cell distribution width and hematocrit for short-term outcomes and prognosis in colorectal cancer patients undergoing radical surgery.
    Peng D; Li ZW; Liu F; Liu XR; Wang CY
    World J Gastroenterol; 2024 Mar; 30(12):1714-1726. PubMed ID: 38617745
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. PTPLAD1 Regulates PHB-Raf Interaction to Orchestrate Epithelial-Mesenchymal and Mitofusion-Fission Transitions in colorectal cancer.
    Huang ZJ; Li YJ; Yang J; Huang L; Zhao Q; Lu YF; Hu Y; Zhang WX; Liang JZ; Pan J; Pan YL; He QY; Wang Y
    Int J Biol Sci; 2024; 20(6):2202-2218. PubMed ID: 38617530
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Lectin-Based Immunophenotyping and Whole Proteomic Profiling of CT-26 Colon Carcinoma Murine Model.
    Faragó A; Zvara Á; Tiszlavicz L; Hunyadi-Gulyás É; Darula Z; Hegedűs Z; Szabó E; Surguta SE; Tóvári J; Puskás LG; Szebeni GJ
    Int J Mol Sci; 2024 Apr; 25(7):. PubMed ID: 38612832
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Integration of pathologic characteristics, genetic risk and lifestyle exposure for colorectal cancer survival assessment.
    Xin J; Gu D; Li S; Qian S; Cheng Y; Shao W; Ben S; Chen S; Zhu L; Jin M; Chen K; Hu Z; Zhang Z; Du M; Shen H; Wang M
    Nat Commun; 2024 Apr; 15(1):3042. PubMed ID: 38589358
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Clinical study on simultaneous resection of liver metastases combined with hyperthermic intraperitoneal chemotherapy for synchronous colorectal cancer liver metastasis.
    Li W; Ren H; Mou H; Li J; Dong L; Li G; Xing M
    J Gastrointest Surg; 2024 Apr; 28(4):425-433. PubMed ID: 38583892
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Vitamin C enhances co-localization of novel TET1 nuclear bodies with both Cajal and PML bodies in colorectal cancer cells.
    El Osmani N; Prévostel C; Picque Lasorsa L; El Harakeh M; Radwan Z; Mawlawi H; El Sabban M; Shirinian M; Dassouki Z
    Epigenetics; 2024 Dec; 19(1):2337142. PubMed ID: 38583183
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Effect of probiotics and synbiotics on complications of wound infection after colorectal surgery: A meta-analysis.
    Jiang J; Ren F
    Int Wound J; 2024 Apr; 21(4):e14838. PubMed ID: 38577937
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Impact of severe postoperative complications on the prognosis of older patients with colorectal cancer: a two-center retrospective study.
    Matsubara D; Soga K; Ikeda J; Kumano T; Mitsuda M; Konishi T; Komatsu S; Shimomura K; Taniguchi F; Shioaki Y; Otsuji E
    BMC Gastroenterol; 2024 Apr; 24(1):125. PubMed ID: 38566007
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. XELOX (capecitabine plus oxaliplatin) plus bevacizumab (anti-VEGF-A antibody) with or without adoptive cell immunotherapy in the treatment of patients with previously untreated metastatic colorectal cancer: a multicenter, open-label, randomized, controlled, phase 3 trial.
    Pan QZ; Zhao JJ; Liu L; Zhang DS; Wang LP; Hu WW; Weng DS; Xu X; Li YZ; Tang Y; Zhang WH; Li JY; Zheng X; Wang QJ; Li YQ; Xiang T; Zhou L; Yang SN; Wu C; Huang RX; He J; Du WJ; Chen LJ; Wu YN; Xu B; Shen Q; Zhang Y; Jiang JT; Ren XB; Xia JC
    Signal Transduct Target Ther; 2024 Apr; 9(1):79. PubMed ID: 38565886
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. A new clinical model for predicting lymph node metastasis in T1 colorectal cancer.
    Wang K; He H; Lin Y; Zhang Y; Chen J; Hu J; He X
    Int J Colorectal Dis; 2024 Apr; 39(1):46. PubMed ID: 38565736
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Prognostic value of depression and anxiety on colorectal cancer-related mortality: a systematic review and meta-analysis based on univariate and multivariate data.
    Xia S; Zhu Y; Luo L; Wu W; Ma L; Yu L; Li Y
    Int J Colorectal Dis; 2024 Apr; 39(1):45. PubMed ID: 38563889
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Regorafenib and glioblastoma: a literature review of preclinical studies, molecular mechanisms and clinical effectiveness.
    Mongiardi MP; Pallini R; D'Alessandris QG; Levi A; Falchetti ML
    Expert Rev Mol Med; 2024 Apr; 26():e5. PubMed ID: 38563164
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. [colorectal adenocarcinoma with enteroblastic differentiation: a clinicopathological analysis of eight cases].
    Wang Q; Zhang Y; Tan C; Ni SJ; Huang D; Chang B; Sheng WQ; Wang L
    Zhonghua Bing Li Xue Za Zhi; 2024 Apr; 53(4):370-376. PubMed ID: 38556821
    [No Abstract]    [Full Text] [Related]  

  • 18. mFOLFIRINOX versus mFOLFOX 6 as adjuvant treatment for high-risk stage III colon cancer - the FROST trial: study protocol for a multicenter, randomized controlled, phase II trial.
    Lee KH; Yang IJ; Ha GW; Lee J; Park YY; Lee SH; Lee JM; Bae JH; Park EJ; Kim H; Kim KY; An S; Kim IY; Kim JY
    BMC Cancer; 2024 Mar; 24(1):397. PubMed ID: 38553680
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Mechanistic insights into FEN1-mediated drug sensitivity and risk signature in colon cancer: An integrative bioinformatics study.
    Rao C; Tong J; Yang Y
    Medicine (Baltimore); 2024 Mar; 103(13):e37517. PubMed ID: 38552056
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. High Oestrogen receptor alpha expression correlates with adverse prognosis and promotes metastasis in colorectal cancer.
    Topi G; Satapathy SR; Ghatak S; Hellman K; Ek F; Olsson R; Ehrnström R; Lydrup ML; Sjölander A
    Cell Commun Signal; 2024 Mar; 22(1):198. PubMed ID: 38549115
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 407.